Percentage calculated from 17 of out 19 patients: one patient died for reasons other than the neurostimulator and in another patient the electrode was removed owing to infection. § [Nikka et al., ...

Synergia Medical has successfully implanted the first two patients in a study evaluating its neurostimulation technology ... up from $5.7bn in 2023. Medtronic is currently the leader in terms ...

"Today, neurostimulators that treat OAB are large ... It is a field currently dominated by Minnesota-based medical device giant Medtronic whose InterStim sacral neuromodulation (SNM) implant ...